Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05259410 · ClinicalTrials.gov registry record · NA
Time Restricted Eating During Chemotherapy for Breast Cancer
A NA study of Breast Cancer Female, sponsored by University of Illinois at Chicago.
- Recruiting
- Registry status
- NA
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT05259410 is a NA study of Breast Cancer Female that is actively recruiting participants, run by University of Illinois at Chicago. The registered enrollment target is 40 participants, below the 692-participant average among 46 other Breast Cancer Female trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05259410, a NA study of Breast Cancer Female, is actively recruiting participants, sponsored by University of Illinois at Chicago.
- RECRUITING
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
Breast cancer is the most common cancer in the United States however, little is known about how diet can affect cancer treatment. Pre-clinical murine studies report intermittent fasting increases effectiveness of chemotherapy and decreases treatment related adverse events. The proposed research will demonstrate that time restricted eating, a form of intermittent fasting, will improve treatment related outcomes, patient related outcomes, and limit treatment related weight gain and fat mass accretion.Time restricted eating combined with a mediterranean diet will also be feasible and improve cardiometabolic risk more than TRE alone or standard care.
Conditions Studied
Interventions
- BEHAVIORAL TRE
- BEHAVIORAL MedTRE
Study Locations (1)
Illinois
- University of Illinois Chicago - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2022-08-01 |
| Est. Completion | 2026-03-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05259410
The ClinicalTrials.gov registry entry for NCT05259410 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 692-participant average among 46 other Breast Cancer Female trials with a reported enrollment target (94% lower). The listed sponsor is University of Illinois at Chicago, which has 430 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Breast Cancer Female appearing as the primary indexed condition, and to 2 interventions - of which TRE is the first listed.
NCT05259410 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.
Frequently Asked Questions
What is clinical trial NCT05259410 about?
NCT05259410 is a clinical study titled "Time Restricted Eating During Chemotherapy for Breast Cancer". Breast cancer is the most common cancer in the United States however, little is known about how diet can affect cancer treatment. Pre-clinical murine studies report intermittent fasting increases effectiveness of chemotherapy and decreases treatment related adverse events. The proposed research will...
What is the current status of trial NCT05259410?
This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2022-08-01. Estimated completion is 2026-03-01.
What conditions does trial NCT05259410 study?
This clinical trial studies the following conditions: Breast Cancer Female.
What interventions are being tested in trial NCT05259410?
The interventions under investigation include: TRE (BEHAVIORAL), MedTRE (BEHAVIORAL).
Who is sponsoring clinical trial NCT05259410?
This trial is sponsored by University of Illinois at Chicago, which has 430 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05259410 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer Female
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)
RECRUITING · NA
-
Resistance and Aerobic Exercise for Prevention in Women With Dense Breasts (REP-D)
RECRUITING · NA
-
Breast Cancer Resiliency Through Exercise Program (B-REP)
RECRUITING · NA
-
Faith in Action! A Church-Based Navigation Model to Increase Breast Cancer Screening in Korean Women
RECRUITING · NA
-
TeleHealth Resistance Exercise Intervention to Preserve Dose Intensity and Vitality in Elder Breast Cancer Patients
RECRUITING · NA
-
Cognitive Rehabilitation Following Breast Cancer Treatment
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.